-
By John K. Waters
Stand Up to Cancer (SU2C) has announced a partnership with technology firm SandboxAQ aimed at accelerating the development of cancer treatments through advanced artificial intelligence tools.
Read More
-
By John K. Waters
SIME Diagnostics, a UK-based medical technology firm, has completed a clinical study evaluating an artificial intelligence-powered Lung Maturity Test (LMT) designed to identify respiratory risks in late-preterm newborns in the United States.
Read More
-
By John K. Waters
OpenAI launches HealthBench, a massive new benchmark that's the company's first major independent health care project.
Read More
-
By John K. Waters
Life sciences software company ACTO has announced an upcoming release of its next-generation Life Sciences AI Conversational Assistant (LAICA), aimed at improving information access and interaction quality for pharmaceutical field teams.
Read More
-
By John K. Waters
Global medical technology firm BD (Becton, Dickinson and Company) has launched a new cell analysis instrument that combines two advanced technologies—spectral flow cytometry and real-time cell imaging—into a single platform, aiming to expand the range of cell-based experiments in biomedical research.
Read More
-
By John K. Waters
Minnesota-based medtech firm iotaMotion has announced the first use of its iotaSOFT Insertion System outside the United States as part of a pre-market clinical investigation at the University Hospital of Zurich in Switzerland.
Read More
-
By John K. Waters
AI and quantum computing company SandboxAQ has announced a new collaboration with NVIDIA aimed at accelerating breakthroughs in drug development, therapeutic design, and medical imaging through the deployment of a new AI platform built on NVIDIA's DGX Cloud infrastructure.
Read More
-
By John K. Waters
Voice AI company Deepgram has unveiled Nova 3 Medical, a next-generation speech-to-text model built specifically for the healthcare sector, claiming it delivers the most accurate real-time medical transcription on the market.
Read More
-
By John K. Waters
PDS Health announces the launch of PDS Health Technologies, a new division aimed at extending its data-driven care infrastructure and expanding access to integrated electronic health record (EHR) solutions across a broader network of providers.
Read More
-
By John K. Waters
The global market for nanotechnology in medical devices is set for significant growth, driven by technological advancements, increasing healthcare demands, and a shift towards precision medicine. According to a newly released report by Research And Markets, the sector was valued at $3.4 billion in 2024 and is projected to reach $4.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.4%.
Read More
-
By John K. Waters
GE HealthCare is expanding its artificial intelligence (AI) partnership with Nvidia to develop autonomous X-ray and ultrasound systems, aiming to alleviate radiology staff shortages and enhance imaging capabilities.
Read More
-
More than 80 percent of healthcare professionals surveyed for a recent Nvidia report credited AI use for helping increase their revenues.
Read More
-
An AI system designed for medical reasoning has advanced beyond diagnosis to support disease treatment and management, according to researchers.
Read More
-
By John K. Waters
The global artificial kidney market is projected to grow at a compound annual growth rate of approximately 13% by 2032, driven by increasing cases of chronic kidney disease (CKD) and end-stage renal disease (ESRD), according to a new report by DelveInsight Business Research.
Read More
-
By John K. Waters
FAIR Health, an independent nonprofit that collects data for and manages one of the nation's largest databases of privately billed health insurance claims, has launched a shared decision-making tool for Alzheimer's disease that features clinical information for self-care and drug therapy options, as well as related cost information.
Read More
-
By John K. Waters
NeuralCure AI, a healthcare technology company specializing in artificial intelligence-driven diagnostics and treatment simulations, announced Tuesday the launch of a new platform aimed at expediting medical research and personalized treatment development. The company also opened a fundraising round to expand its capabilities and partnerships.
Read More